Annual FCF
-$43.74 M
+$22.71 M+34.17%
31 December 2022
Summary:
Calithera Biosciences annual free cash flow is currently -$43.74 million, with the most recent change of +$22.71 million (+34.17%) on 31 December 2022. During the last 3 years, it has risen by +$22.71 million (+34.17%). CALA annual FCF is now -449.31% below its all-time high of $12.52 million, reached on 31 December 2017.CALA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$8.62 M
-$885.00 K-11.44%
31 December 2022
Summary:
Calithera Biosciences quarterly free cash flow is currently -$8.62 million, with the most recent change of -$885.00 thousand (-11.44%) on 31 December 2022. CALA quarterly FCF is now -124.49% below its all-time high of $35.20 million, reached on 31 March 2017.CALA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$43.74 M
+$16.99 M+27.98%
31 December 2022
Summary:
Calithera Biosciences TTM free cash flow is currently -$43.74 million, with the most recent change of +$16.99 million (+27.98%) on 31 December 2022. CALA TTM FCF is now -316.27% below its all-time high of $20.23 million, reached on 30 June 2017.CALA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CALA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +34.2% | +66.3% | +34.2% |
| 5 y5 years | +44.5% | +53.1% | +44.5% |
CALA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +34.2% | -11.4% | +66.3% | at high | +34.2% |
| 5 y | 5 years | at high | +48.2% | -11.8% | +68.1% | at high | +48.6% |
| alltime | all time | -449.3% | +48.2% | -124.5% | +68.1% | -316.3% | +48.6% |
Calithera Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$43.74 M(-34.2%) | -$8.62 M(+11.4%) | -$43.74 M(-28.0%) |
| Sept 2022 | - | -$7.74 M(-32.0%) | -$60.73 M(+0.0%) |
| June 2022 | - | -$11.37 M(-29.0%) | -$60.71 M(+0.4%) |
| Mar 2022 | - | -$16.01 M(-37.5%) | -$60.45 M(-9.0%) |
| Dec 2021 | -$66.45 M(-21.2%) | -$25.61 M(+232.0%) | -$66.45 M(+4.0%) |
| Sept 2021 | - | -$7.71 M(-30.6%) | -$63.87 M(-11.9%) |
| June 2021 | - | -$11.12 M(-49.5%) | -$72.47 M(-8.7%) |
| Mar 2021 | - | -$22.00 M(-4.5%) | -$79.35 M(-6.0%) |
| Dec 2020 | -$84.37 M(+7.1%) | -$23.04 M(+41.2%) | -$84.37 M(+5.8%) |
| Sept 2020 | - | -$16.31 M(-9.3%) | -$79.73 M(-4.1%) |
| June 2020 | - | -$18.00 M(-33.4%) | -$83.10 M(-2.4%) |
| Mar 2020 | - | -$27.03 M(+46.9%) | -$85.16 M(+8.1%) |
| Dec 2019 | -$78.75 M(+21.1%) | -$18.39 M(-6.6%) | -$78.75 M(+6.0%) |
| Sept 2019 | - | -$19.68 M(-1.8%) | -$74.28 M(+4.2%) |
| June 2019 | - | -$20.05 M(-2.8%) | -$71.28 M(+0.8%) |
| Mar 2019 | - | -$20.62 M(+48.2%) | -$70.70 M(+8.7%) |
| Dec 2018 | -$65.06 M | -$13.92 M(-16.6%) | -$65.06 M(+3.2%) |
| Sept 2018 | - | -$16.68 M(-14.3%) | -$63.05 M(+8.5%) |
| June 2018 | - | -$19.48 M(+30.0%) | -$58.12 M(+54.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$14.98 M(+25.8%) | -$37.66 M(-400.7%) |
| Dec 2017 | $12.52 M(-139.8%) | -$11.91 M(+1.3%) | $12.52 M(-19.2%) |
| Sept 2017 | - | -$11.76 M(-1286.7%) | $15.49 M(-23.4%) |
| June 2017 | - | $991.00 K(-97.2%) | $20.23 M(+75.2%) |
| Mar 2017 | - | $35.20 M(-493.9%) | $11.55 M(-136.7%) |
| Dec 2016 | -$31.43 M(+3.5%) | -$8.94 M(+27.1%) | -$31.43 M(-3.3%) |
| Sept 2016 | - | -$7.03 M(-8.6%) | -$32.50 M(+1.8%) |
| June 2016 | - | -$7.69 M(-1.1%) | -$31.92 M(+4.8%) |
| Mar 2016 | - | -$7.77 M(-22.4%) | -$30.45 M(+0.3%) |
| Dec 2015 | -$30.37 M(+53.5%) | -$10.02 M(+55.3%) | -$30.37 M(+22.0%) |
| Sept 2015 | - | -$6.45 M(+3.7%) | -$24.90 M(+2.0%) |
| June 2015 | - | -$6.22 M(-19.2%) | -$24.41 M(+6.6%) |
| Mar 2015 | - | -$7.69 M(+69.4%) | -$22.90 M(+15.7%) |
| Dec 2014 | -$19.79 M(+64.9%) | -$4.54 M(-23.8%) | -$19.79 M(+29.8%) |
| Sept 2014 | - | -$5.96 M(+26.7%) | -$15.25 M(+64.2%) |
| June 2014 | - | -$4.70 M(+2.6%) | -$9.29 M(+102.6%) |
| Mar 2014 | - | -$4.58 M | -$4.58 M |
| Dec 2013 | -$12.00 M(+70.5%) | - | - |
| Dec 2012 | -$7.04 M | - | - |
FAQ
- What is Calithera Biosciences annual free cash flow?
- What is the all time high annual FCF for Calithera Biosciences?
- What is Calithera Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Calithera Biosciences?
- What is Calithera Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Calithera Biosciences?
What is Calithera Biosciences annual free cash flow?
The current annual FCF of CALA is -$43.74 M
What is the all time high annual FCF for Calithera Biosciences?
Calithera Biosciences all-time high annual free cash flow is $12.52 M
What is Calithera Biosciences quarterly free cash flow?
The current quarterly FCF of CALA is -$8.62 M
What is the all time high quarterly FCF for Calithera Biosciences?
Calithera Biosciences all-time high quarterly free cash flow is $35.20 M
What is Calithera Biosciences TTM free cash flow?
The current TTM FCF of CALA is -$43.74 M
What is the all time high TTM FCF for Calithera Biosciences?
Calithera Biosciences all-time high TTM free cash flow is $20.23 M